CHICAGO — Adjunctive treatment did not reduce the rate of retinal detachment in acute retinal necrosis more than the gold standard treatment of systemic antivirals alone, according to a study presented here.
At the American Academy of Ophthalmology meeting, Ines Lains, MD, PhD, said acute retinal necrosis (ARN) is a rare viral infection that leads to high rates of retinal detachment.
“Currently, the standard treatment of ARN is with systemic antivirals,” she said. “However, these patients frequently have poor outcomes, so clinicians add adjunctive treatments in an effort